In Vitro Fertilization-Embryo Transfer Outcome in Advanced Women

Sunita Bhandari

2009-01-01

Abstract:【Objective】 To explore the appropriate age for IVF-ET treatment and the factors impact on advanced women in vitro fertilization-embryo transfer (IVF-ET). 【Methods】 Statistic analysis has been done for the IVF-ET women from November 1999 to June 2006 in the Reproductive Center of tertiary hospital. ≥35 years old women 2 144 cycles, and 5559 cycles 35 years old;≥35 and 35 years old as well as 35 ～ 36,37 ～ 38,39 ～ 40 and over 41 years old cycles had been compared respectively in this study. 【Results】 The pregnancy rate, the embryo implantation rate, the premature delivery rate, and take home baby rate were significantly different between the ≥ 35-year-old group and 35-year-old group (P 0.001). However, in the patients over 35 years old, secondery infertility rate, female infertility rate, and endometriosis rate were 70.3%, 69.9% and 14.9%, seperately, which were significantly higher than those rates in the group less than 35 years old(51.7%, 37.5%, and 9.5% seperately, P 0.001). Patients with polycystic ovary syndrome count 1.9% in the group over 35 years old, which was significantly lower than that in the group less that 35 years old (3.7%, P 0.001). Furthermore, although the pregnancy rate, the embryo implantation rate, the premature delivery rate and take home baby rate were significantly different among patients in the 35-year-old, 35-36, and 37-38 age groups, significant differences were only found in those rates between the patients over and less than 38 years old. No differences were found among those rates in the group of 35-year-old, 35-36, 37-38 age in IVF-ET ICSI cycle for male infertility. 【Conclusion】 The declined IVF-ET pregnancy rate of advanced women was not only affected by the age but also affected by their gynecological diseases. It seems that age 38 or older were the threshold for the good outcome of IVF treatment, and the treatment strategy should be improvement except the primary infertility disease screening and treatment in this group of advanced women.